• Featured Product
  • KD/KO Validated

LASS2 Polyclonal antibody

LASS2 Polyclonal Antibody for IHC, IP, WB, ELISA

Host / Isotype

Rabbit / IgG


human, mouse, rat





Cat no : 20344-1-AP


CerS2, L3, LASS2, SP260, TMSG1

Tested Applications

Positive WB detected inmouse liver tissue, HeLa cells, HepG2 cells, rat liver tissue
Positive IP detected inHeLa cells
Positive IHC detected inhuman liver tissue, mouse lung tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

Western Blot (WB)WB : 1:1000-1:4000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB
Immunohistochemistry (IHC)IHC : 1:50-1:500
Sample-dependent, check data in validation data gallery

Product Information

The immunogen of 20344-1-AP is LASS2 Fusion Protein expressed in E. coli.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen LASS2 fusion protein Ag14151
Full Name LAG1 homolog, ceramide synthase 2
Calculated molecular weight 380 aa, 45 kDa
Observed molecular weight 45 kDa
GenBank accession numberBC010032
Gene symbol LASS2
Gene ID (NCBI) 29956
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

LASS2, also known as TMSG1, is a novel suppressor of human cancer metastasis. As one member of LASS family, including LASS1-6, LASS2 mRNA is at the highest level of all LASS members, and has the broadest tissue distribution, particularly abundant in the liver, kidney and brain in mice. The biological roles of LASS2 include protection from aging , hepatic INS resistance, and hepatocellular carcinoma (HCC) progression. LASS2 has been correlated with the degree of invasion and recurrence of carcinomas of the prostate, liver, breast and bladder.


Product Specific Protocols
WB protocol for LASS2 antibody 20344-1-APDownload protocol
IHC protocol for LASS2 antibody 20344-1-APDownload protocol
IP protocol for LASS2 antibody 20344-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Cardiovasc Res

Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure.

Authors - Linda Sasset
  • KD Validated

J Cancer

LASS2 impairs proliferation of glioma stem cells and migration and invasion of glioma cells mainly via inhibition of EMT and apoptosis promotion.

Authors - Wei-Jiang Zhao
  • KD Validated

Exp Cell Res

MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.

Authors - Ting Luan
  • KD Validated

J Cancer

LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.

Authors - Lijuan Huang
  • KD Validated

Tumour Biol

miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.

Authors - Haifeng Wang